Cover image of the article: Tissue Distribution of 125I-human Nonspecific Polyclonal IgG in Normal and Induced Inflammation Mice

Image Credit:Iran J Pharm Res

Tissue Distribution of 125I-human Nonspecific Polyclonal IgG in Normal and Induced Inflammation Mice

Authors

Soraya Shahhosseini1,*, Mohammad Hossein Babaei2, Reza Najafi2
1a Department of Pharmacetical Chemistry, School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services, Tehran, Iran
2Radioisotopes Division, Nuclear Research Center, Atomic Energy Organization of Iran, Tehran, Iran
*Corresponding Author: a Department of Pharmacetical Chemistry, School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services, Tehran, Iran. Email: sshahhosseini@irimc.org

Iranian Journal of Pharmaceutical Research:Vol. 1, issue 1; 55-59
Published online:Nov 20, 2010
Article type:Research Article
Received:Apr 01, 2002
Accepted:Jul 01, 2002
How to Cite:Shahhosseini S, Babaei MH, Najafi R. Tissue Distribution of 125I-human Nonspecific Polyclonal IgG in Normal and Induced Inflammation Mice. Iran J Pharm Res. 2002;1(1):e127587. doi: https://doi.org/10.22037/ijpr.2010.11

Abstract

Many different radiolabeled antibodies have been used for radioimmunotherapy and radioimmunoscintigraphy of human diseases in animal experiments. In order to study the in vivo tissue distribution of antibody, we labeled human nonspecific polyclonal IgG with Na125I using chloramine-T method. An animal model was developed by injecting turpentine in the posterior left thigh of Balb/c mice. Tissue distribution of 125I-IgG was assessed in normal and induced inflammation mice. Although labeled IgG accumulated in normal tissues such as liver, spleen and blood, its localization in inflammatory left thigh was significantly different from normal right thigh. Thus, by using the radiolabeling methods of IgG in order to increase the target-to-background ratio, antibody scintigraphy could be suggested as a powerful diagnostic tool for inflammation.

Highlights

Copyright

© 2002, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Dec
2018
Preparation of 177Lu-Rituximab and Comparison with 131I-Rituximab Radiolabeled with Chloramine-T Method

Preparation of 177Lu-Rituximab and Comparison with 131I-Rituximab Radiolabeled with Chloramine-T Method

Fariba Johari Daha,
Samira Rasaneh,
Saleh Salehi Zahabi

Johari Daha F, Rasaneh S, Salehi Zahabi S. Preparation of 177Lu-Rituximab and Comparison with 131I-Rituximab Radiolabeled with Chloramine-T Method. J Clin Res Paramed Sci. 2018;7(2):e87181. doi: https://doi.org/10.5812/jcrps.87181

31
Oct
2018
Influence of DOTA Chelators on Radiochemical Purity and Biodistribution of 177Lu- and 90Y-Rituximab in Xenografted Mice

Influence of DOTA Chelators on Radiochemical Purity and Biodistribution of 177Lu- and 90Y-Rituximab in Xenografted Mice

Urszula Karczmarczyk,
Wioletta Wojdowska,
Renata Mikołajczak,
Michał Maurin,
Ewa Laszuk,
Piotr Garnuszek

Karczmarczyk U, Wojdowska W, Mikołajczak R, Maurin M, Laszuk E, et al. Influence of DOTA Chelators on Radiochemical Purity and Biodistribution of 177Lu- and 90Y-Rituximab in Xenografted Mice. Iran J Pharm Res. 2018;17(4):e124873. doi: https://doi.org/10.22037/ijpr.2018.2298

30
Apr
2012
Preparation and Biodistribution Studies of a Radiogallium-Acetylacetonate Bis (Thiosemicarbazone) Complex in Tumor-Bearing Rodents

Preparation and Biodistribution Studies of a Radiogallium-Acetylacetonate Bis (Thiosemicarbazone) Complex in Tumor-Bearing Rodents

Amir Reza Jalilian,
Hassan Yousefnia,
Kamaleddin Shafaii,
Aytak Novinrouz,
Amir Abbas Rajamand

Jalilian AR, Yousefnia H, Shafaii K, Novinrouz A, Rajamand AA. Preparation and Biodistribution Studies of a Radiogallium-Acetylacetonate Bis (Thiosemicarbazone) Complex in Tumor-Bearing Rodents. Iran J Pharm Res. 2012;11(2):e125870. doi: https://doi.org/10.22037/ijpr.2012.1090

30
Apr
2013
Production and Quality Control of [67Ga]-DOTA-trastuzumab for Radioimmunoscintigraphy

Production and Quality Control of [67Ga]-DOTA-trastuzumab for Radioimmunoscintigraphy

Behrooz Alirezapour,
Amir R. Jalilian,
Fatemeh Bolourinovin,
Sedigheh Moradkhani

Alirezapour B, R. Jalilian A, Bolourinovin F, Moradkhani S. Production and Quality Control of [67Ga]-DOTA-trastuzumab for Radioimmunoscintigraphy. Iran J Pharm Res. 2013;12(2):e125694. doi: https://doi.org/10.22037/ijpr.2013.1314

5
Aug
2015
99mTc-IgG-Lung Scintigraphy in the Assessment of Pulmonary Involvement in Interstitial Lung Disease and Its Comparison With Pulmonary Function Tests and High-Resolution Computed Tomography: A Preliminary Study

99mTc-IgG-Lung Scintigraphy in the Assessment of Pulmonary Involvement in Interstitial Lung Disease and Its Comparison With Pulmonary Function Tests and High-Resolution Computed Tomography: A Preliminary Study

Mehrzad Bahtouee,
Jamshid Saberifard,
Hamid Javadi,
Iraj Nabipour,
Hasan Malakizadeh,
Gholamhossein Monavvarsadegh
,et al.

Bahtouee M, Saberifard J, Javadi H, Nabipour I, Malakizadeh H, et al. 99mTc-IgG-Lung Scintigraphy in the Assessment of Pulmonary Involvement in Interstitial Lung Disease and Its Comparison With Pulmonary Function Tests and High-Resolution Computed Tomography: A Preliminary Study. I J Radiol. 2015;12(4):e14619. doi: https://doi.org/10.5812/iranjradiol.14619v2

More by these authors

Soraya ShahhosseiniPubMedScholar
Mohammad Hossein BabaeiPubMedScholar
Reza NajafiPubMedScholar
Share
Cited by
Metrics